SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): November 18, 2009
COHERENT, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
000-05255 |
|
94-1622541 |
(State or other jurisdiction of incorporation) |
|
(Commission File No.) |
|
(IRS Employer Identification Number) |
5100 Patrick Henry Drive
Santa Clara, CA 95054
(Address of principal executive offices)
(408) 764-4000
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 18, 2009, Mr. Clifford Press resigned from the registrants board of directors. At the time of his resignation, Mr. Press was also a member of the nominating and governance committee. Mr. Press resignation letter is attached as Exhibit 99.1 to this form 8-K.
ITEM 9.01 Financial Statements and Exhibits
(d) EXHIBITS:
Exhibit No. |
|
Description |
|
|
|
99.1 |
|
Letter dated November 18, 2009 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
COHERENT, INC. |
|
Date: November 19, 2008 |
|
|
|
By: |
/s/ Bret M. DiMarco |
|
Bret M. DiMarco |
|
|
Executive Vice President and General Counsel |
3